DCF — MARSHALL HOSPITAL
Enterprise Value: $-290.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-290.8M
Enterprise Value
$-95.8M
PV of Cash Flows
$-195.0M
PV of Terminal Value
$-314.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $294.6M | $-16.0M | -5.0% | $-28.5M | $-25.9M |
| Year 2 | $303.4M | $-13.5M | -4.0% | $-26.3M | $-21.8M |
| Year 3 | $312.5M | $-10.8M | -3.0% | $-24.0M | $-18.0M |
| Year 4 | $321.9M | $-9.5M | -3.0% | $-23.1M | $-15.8M |
| Year 5 | $331.5M | $-8.9M | -3.0% | $-23.0M | $-14.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-290.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$286.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0594836166572946
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5